Advanced dual-peptide research blend studied in endocrine and growth hormone signaling-focused laboratory applications.

CJC-1295 + Ipamorelin (Without DAC) is a premium dual-peptide research formulation extensively studied in endocrine signaling, growth hormone pathway research, and advanced peptide communication models. Combining a modified growth hormone releasing hormone analog with a selective peptide secretagogue, this investigational blend has become one of the most recognized combinations within modern peptide research environments.

The non-DAC profile of CJC-1295 allows for shorter activity characteristics commonly utilized in precision-focused laboratory protocols exploring peptide signaling dynamics and endocrine-related investigational applications.

Azyrion Labs CJC-1295 + Ipamorelin (Without DAC) is manufactured to rigorous laboratory-grade standards emphasizing purity, consistency, and advanced scientific integrity.

Research Attributes

• Advanced dual-peptide formulation
• Non-DAC precision signaling profile
• High-purity laboratory-grade manufacturing
• Precision-controlled research standards
• Premium biotech-quality packaging

Storage

Maintain refrigerated storage conditions and protect from excessive heat or direct light exposure.